| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/07/2005 | US20050074440 Lactobacillus rhamnosus strain and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | US20050074411 Synthesis of an magnetic resonance imaging (MRI) agent by reacting a peptide with p-xylylenediamine and covalently attaching a linker moiety, reacting with a precursor chelate moiety having protected carboxy groups, deprotecting, and chelating with a paramagnetic metal ion |
| 04/07/2005 | US20050074386 Low water uptake silicas |
| 04/07/2005 | US20050073511 Display for sharing display data channel |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2540104A1 Water soluble nanoparticles comprising inclusion complexes |
| 04/07/2005 | CA2539914A1 Small molecule compositions and methods for increasing drug efficiency using compositions thereof |
| 04/07/2005 | CA2539694A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 04/07/2005 | CA2539542A1 Delivery of therapeutic compounds via microparticles or microbubbles |
| 04/07/2005 | CA2538680A1 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| 04/07/2005 | CA2538676A1 Probiotic storage and delivery |
| 04/07/2005 | CA2536139A1 Nucleic acid-lipophilic conjugates |
| 04/06/2005 | EP1520850A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 04/06/2005 | EP1520581A1 Composition based on a thiazolidinedione and metformin and its use |
| 04/06/2005 | EP1520579A1 Compositions for the treatment and prevention of cancer |
| 04/06/2005 | EP1520578A1 Medicinal suspensions |
| 04/06/2005 | EP1519979A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 04/06/2005 | EP1519962A1 Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519757A1 Scanning suspension comprising a particle with a diameter of at least 1 micrometer |
| 04/06/2005 | EP1519747A2 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 04/06/2005 | EP1519745A1 Method to enhance an immune response of nucleic acid vaccination |
| 04/06/2005 | EP1519744A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 04/06/2005 | EP1519737A2 Fibrin nanoparticles and uses thereof |
| 04/06/2005 | EP1519734A1 Ciclesonide-containing sterile aqueous suspension |
| 04/06/2005 | EP1519724A1 Fredericamycin derivatives as medicaments for treating tumours |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1519718A1 At least partially degradable films containing an active ingredient and method for the production thereof |
| 04/06/2005 | EP1519717A1 Controlled release composition |
| 04/06/2005 | EP1519714A1 Method and apparatus for producing liposomes |
| 04/06/2005 | EP1519713A2 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| 04/06/2005 | EP1519707A1 Method and composition for improving sensory characteristics of semisolid predominantly anhydrous lipids |
| 04/06/2005 | EP1519704A2 Spherical pellet containing a water-soluble active ingredient |
| 04/06/2005 | EP1280499A4 Polymeric delivery and release systems for oral care actives |
| 04/06/2005 | EP1248652B1 Stable aqueous deoxyfructosazine solution |
| 04/06/2005 | EP1231918B1 Novel composition based on a thiazolidinedione and metformin and use |
| 04/06/2005 | EP1212100B1 Delivery system for antidandruff agent |
| 04/06/2005 | EP1006964B1 Intrauterine chemical necrosing compositions and apparatus |
| 04/06/2005 | EP0988029B1 Device and methods for wound treatment |
| 04/06/2005 | EP0981373B1 Biofunctional polymers prepared in supercritical fluid |
| 04/06/2005 | EP0802790B1 Transdermal therapeutic system for dispensing (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts |
| 04/06/2005 | EP0801561B1 Composition and methods for transdermal delivery of acid-labile drugs |
| 04/06/2005 | EP0663013B1 Method for delivering nucleic acids into cells |
| 04/06/2005 | EP0553244B2 Targeted immunostimulation with bispecific reagents |
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1604899A Hydroxycucurbituril derivatives, their preparation methods and uses |
| 04/06/2005 | CN1604793A Methods of treatment and formulations of cephalosporin |
| 04/06/2005 | CN1604792A Agents for enhancing the immune response |
| 04/06/2005 | CN1604790A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 04/06/2005 | CN1604788A High-concentration protein formulations and method of manufacture |
| 04/06/2005 | CN1604787A Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 04/06/2005 | CN1604784A Heparin-containing ophthalmic agent |
| 04/06/2005 | CN1604782A Stabilized brivudine topical formulations |
| 04/06/2005 | CN1604772A Transdermal transport of compounds |
| 04/06/2005 | CN1604770A Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs |
| 04/06/2005 | CN1602961A Ointment auxiliary agent and preparation thereof |
| 04/06/2005 | CN1602881A Diabetin for injection and its preparation process |
| 04/06/2005 | CN1602850A Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method |
| 04/06/2005 | CN1195788C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2005 | CN1195551C Novel agent for controlling cell activity |
| 04/06/2005 | CN1195550C External preparation |
| 04/06/2005 | CN1195549C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 04/06/2005 | CN1195548C Stable mitoxantron solutions |
| 04/06/2005 | CN1195545C Vaginal suppository vaccine for urogenital infections |
| 04/06/2005 | CN1195542C Preventives for hepatopathy |
| 04/06/2005 | CN1195523C Topical compositions for prostaglandin E1 delivery |
| 04/06/2005 | CN1195510C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 04/06/2005 | CN1195506C Transdermal therapeutic system with improved stability and method for production thereof |
| 04/06/2005 | CN1195505C Microreservoir system on basis of polysiloxanes and ambiphilic solvents |
| 04/06/2005 | CN1195504C Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 04/06/2005 | CN1195503C Transdermal patch and topical compositions comprising propylnorapomorphine |
| 04/06/2005 | CN1195501C Transdermal therapeutic system (TTS) for administrating sexual steroid hormones |
| 04/06/2005 | CN1195500C Orally disintegrable tablet |
| 04/06/2005 | CN1195499C Enteric coated pharmaceutical tablet and method of manufacturing |
| 04/06/2005 | CN1195498C Directly compressed solid dosage particles |
| 04/06/2005 | CN1195497C Biodegradable polymer encapsulated 5-hydroxytryptamine receptor antagonist and method for preparing the same |
| 04/06/2005 | CN1195495C Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/06/2005 | CN1195494C Oral liquid mucoadhesive compositions |
| 04/06/2005 | CN1195493C Absorbable silicon implants containing beneficial substance |
| 04/06/2005 | CN1195415C Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/05/2005 | US6875862 Radiating with radioactive rays a mixture of an alkyl, a hydroxyalkyl and/or carboxyalkyl cellulose; medical products, cosmetics, sanitary products and an agricultural water retention agent; a chromatography carrier; soil improver |
| 04/05/2005 | US6875841 Polyoxyalkylene derivative and process of producing the same |
| 04/05/2005 | US6875840 Overcoating medical equipment with nitrosylated cyclodextrin |
| 04/05/2005 | US6875793 Once-a-day controlled release sulfonylurea formulation |
| 04/05/2005 | US6875749 Methods of facilitating vascular growth |
| 04/05/2005 | US6875748 Sodium and potassium phosphate salts, in aqueous solution, and detergents and surfactants for direct polypeptide delivery into vertebrate cells |
| 04/05/2005 | US6875448 Method of intracellular sustained-release of drug and preparations |
| 04/05/2005 | US6875447 Analgesics; pain therapy; administering by injection |
| 04/05/2005 | US6875446 Method for prophylaxis and/or treatment of thromboembolism |
| 04/05/2005 | US6875443 An alcohol with chain length from about c20-c36 including policosanol, are therapeutically useful materials with efficacy in lowering cholesterol, can be advantageously added to foods such as margarines and salad dressings |
| 04/05/2005 | US6875441 Composition for delivery of hematopoietic growth factor |
| 04/05/2005 | US6875435 In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 04/05/2005 | US6875432 Reduced-viscosity concentrated protein formulations |
| 04/05/2005 | US6874565 Cooling apparatus |
| 04/05/2005 | CA2162280C Use of a polymer material on the basis of modified hydrocolloids as a coating, covering wall material |
| 03/31/2005 | WO2005028539A2 Multi-arm polymer prodrugs |
| 03/31/2005 | WO2005028516A2 Albumin-binding derivatives of therapeutic peptides |
| 03/31/2005 | WO2005028032A1 Injectable therapeutic formulations |
| 03/31/2005 | WO2005027979A2 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |